Synthesis of Minnemod: GMP Grade Apilimod For COVID-19 Clinical Trials 

Dr. Ricardo Battaglino, Professor, Vice Chair of Research, and Dr. Leslie Morse, Professor, Department Head, and Dr. Vadim Gurvich, Director of ITDD Chemical Process and Development Core, were awarded an IEM COVID-19 Rapid Response Grant. 

The grant is designed to catalyze and energize small-scale engineering research projects designed to address and mitigate COVID-19 funded by the Institute for Engineering in Medicine. Learn more about the Rehabilitation Medicine Translational Research Lab's COVID-19 clinic study with Apilimod below. 

Apilimod Clinical Trial

We expect Apilimod to be 100-times more potent than other inhibitors such as hydroxychloroquine and chloroquine that have been tested for COVID-19 treatments. - Ricardo Battaglino, PhD

Share this post

Related News

  • Department welcomes another resident

    On July 1, 2021, another Physical Medicine and Rehabilitation resident began her journey with the department. Jessica Casey, MD, will be completing what’s known as the MUSCLE Curriculum during her residency.

  • What is “long COVID-19” and what are the symptoms?

    This M Health Fairview story explores what experts experienced with COVID-19 treatment and rehabilitation have to say about how the virus may continue to affect the body and what care options are available for COVID “long-haulers.”

  • PhD student embraces interprofessional studies in her facial pain research

    Emily Kahnert, DPT, CCTT, is not a typical PhD student. She calls herself an “unusual combination of a lot of different things here at the University,” saying that she is “blazing some trails in many ways.” Those trails earned her an American Academy of Orofacial Pain Research grant to implement her dissertation research in orofacial pain and TMD.